AN OVERVIEW OF PHARMACOVIGILANCE OF HIV/AIDS IN NIGERIA

Slides:



Advertisements
Similar presentations
June 2009 Feedback to States and Zone Routine Immunization Performance Data as at 15 th July 2009 in National Database.
Advertisements

December 2009 Feedback to States and Zone Routine Immunization Performance Data as at 15 th January 2010 in National Database.
Qtr1 (Jan-Mar 2009) Feedback to States and Zone Routine Immunization Performance Data as at 15 th April 2009 in National Database.
TB & HIV Infection: Treatment
ART SERVICES SCALE UP IN NIGERIA SUCCESSES CHALLENGES and WAY FORWARD TEAM NIGERIA.
HIV Situation in India Dr Sunil Gaikwad.
NIGERIA: THE ROLE OF DEVELOPMENT PARTNERS IN STRENGTHENING THE NATIONAL STATISTICAL SYSTEM By Alain Gaugris, DECDG WORLD BANK National Statistical User.
ARV failure and resistance for the paediatrician
Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
ART: The Basics William Aldis World Health Organization Bangkok, September 14, 2005.
Czech Blades s.r.o. Praha, Czech Republic August 21st, 2013
National Sports Festival: Eko The Sports Festival actually started in 1973 and has been running till date. Except in 1983, 1987, 1993 and 1995,
APPMG World Malaria Day Event, 2013 Invest in The Future: Defeat Malaria Kolawole Maxwell, Malaria Consortium Nigeria Country Director.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Principles of HIV Therapy Simple is Better! Adeel A. Butt, MD Assistant Professor of Medicine and Infectious Diseases University of Pittsburgh Director,
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
StatiSense ® - Wale Micaiah © UTME 2013 Testing Modes: PPBT, DBT & CBT.
12th Prorities in Reproductive Health and HIV Conference Oct 2005, Stellenbosch, South Africa 1 Use of Lemon/Lime Juice Douching by Women To Prevent.
Track B Workshop Controversies in the Management of HIV-positive Adults: A Case-Based Approach Sasisopin Kiertiburanakul, MD, MHS Associate Professor Department.
ELECTORAL RISK MANAGEMENT ELECTION DAY REPORT ON 2015 GOVERNORSHIP AND STATE ASSEMBLY ELECTIONS Prepared by: INEC Electoral Risk Management (ERM) Team.
NIGERIA COUNTRY PRESENTATION By: Drs. Uzono Levi G and Adegboyega Adewumi 4 th September 2004.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
Human Capacity Development and Maternal Mortality Reduction: Distribution and Population Coverage of Obstetricians and Gynecologists in Nigeria BY Agboghoroma.
ANTIRETROVIRAL DRUGS IN THE PERINATAL PERIOD. Use of ARV Drugs by HIV-Infected Pregnant Women and Their Infants  Considerations for choice of ARV drugs.
0 Power Sector Opportunities in Nigeria Dolapo Kukoyi, Partner (Power) UKTI TRADE DELEGATION TO LONDON – SESSION WITH BRITISH EXPERTISE AND THE CITY UK.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
WHO - PSM 14/7/2005 Principles for selection of medicines Dr Mary R. Couper Quality Assurance and Safety of Medicines WHO.
Managing Statistics at States and Federal MDAs level using e-Template Platform under NSS By B i y i F a f u n m i Head (Data Management) National Bureau.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Politics: The Mega Party APC. ACN ANPP APGA CPC APC All Progressive Congress The Mega Party Action Congress of Nigeria All Nigeria Peoples Party All Progressive.
Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd – 28 th November 2009.
HIV-1 dynamics Perelson et.al. Science 271:1582 (1996) Infected CD4 + lymphocytes Uninfected, activated CD4 + lymphocytes HIV-1 t 1/ days t 1/2.
KITSO AIDS Training Program Lecture 1: Introduction to the Botswana National ARV Program (MASA) delivered by Dr. Ndwapi Ndwapi, BHP.
Key1 ARV Treatment Guidelines for a Public Health Approach Product Selection for HIV Treatment Vincent Habiyambere February 2006.
1 NSE AGM ABUJA 2013 “EFFECTIVE FLOOD PLAIN MANAGEMENT IN NIGERIA: ISSUES, BENEFITS AND CHALLENGES” Presenter – Engr. Ikenna Okonkwo – MNSE, COREN Environment.
1 PRESENTATION ON NEW SPECTRUM FEES AND PRICING STRATEGY To Nigerian Telecommunications Operators 11 th December, 2002.
Why African Americans Must Understand and Participate in Clinical Trials and Vaccines Virginia A. Caine, M.D. Associate Professor of Medicine Division.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
Dr Ihor Perehinets MD, MPH National Technical Officer WHO CO in Ukraine Pharmacovigilance (PV) in HIV treatment in Ukraine: Situation Analysis Dar es Salaam.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
National PMS Stock and Distribution Status – 16 TH December National PMS Sufficiency Total Vessel Discharge Vol to Tanks Volume of PMS evacuated.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Side effects of antiretroviral drugs
Slide 1 National Bureau of Statistics Statistical Information Systems Architecture and Application in Nigeria: Continued… By Chuba Moneke Deputy Director.
Global e-Society Complex Citizens’ driven Crowd-Platform for Societal Organization Africa Continent Federal Republic of Nigeria Globplex.
AUTHORS 1Uwem F. Ekpo 2,3Eveline Huerlimann 2,3Nadine Schur
NIGERIA COUNTRY PRESENTATION By: Drs. Uzono Levi G and
Antiretroviral Therapy (ART)
The Presidential Committee On The North East Initiative
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
Drug Pricing Policies and Challenges
chudi s. ubosi – fnivs mrics
Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses 
Pharmacovigilance in Uganda
Giới thiệu về điều trị ARV
USE OF ADMINISTRATIVE DATA AND RECORDS FOR OFFICIAL STATISTICS
"3 by 5" progress December 2005.
12/11/17 LT= I can explain why Nigeria is almost three separate countries. Notes over Nigeria. Powerpoint Kelsey in Nigeria. Lost Boys of Sudan ***TEST.
Oluwole FAJEMISIN 22nd July 2014
GENERATION, IDENTIFICATION, SELECTION OF BUSINESS OPPORTUNITIES
2019 Humanitarian Need Overview Briefing
Antiretroviral therapy for initial human immunodeficiency virus/AIDS treatment: critical appraisal of the evidence from over 100 randomized trials and.
Forecasting for ARVs medicines
ART Use in Selected PEPFAR Countries Forecasting for ARVs to 2010 November 7-8, 2005 Rational Pharmaceutical Management Plus.
EPIDEMIOLOGICAL BURDEN OF TUBERCULOSIS IN NIGERIA August 2003
Hon Commissioner for Health
Antiretroviral therapy and its complications
BOLA TINUBU COLLOQUIUM 28 March 2019
Number of Trainees and Adopters of
Presentation transcript:

AN OVERVIEW OF PHARMACOVIGILANCE OF HIV/AIDS IN NIGERIA Pharm.. H. A. ABOJE (NPC), NAFDAC, Nigeria

Background Information Nigeria is a country in west Africa bordered to the East by Cameroun, the West by Benin Republic, and the North by Niger Republic. Population: Over 140million Total Area: approx. 924,000 Sq/Km Land Area: 910,768Sq/Km Water: 13,OOOSq/Km Geo-Political Zone:Six(6) NO. of States: 36 Capital: Abuja Official Language: English Health Care System: Primary, Secondary & Tertiary

HIV Prevalence by State Emergency Plan Focus States Sokoto Katsina Jigawa Y obe Zamfara Borno Kano Kebbi Kaduna Bauchi Gombe Niger Adamawa Plateau Kwara FCT Nasarawa Oyo KEY Taraba Kogi Emergency Plan Focus States Ekiti >8.0% Osun Benue Ondo Ogun 6.1 – 8.0% Lagos Enugu Edo Anambra Ebonyi 4.1 – 6.0% Cross River Abia 2.1 – 4.0% Delta Imo Akwa Ibom 1.0 – 2.0% Rivers Bayelsa ANC 2008 <1.0% 3 3

HIV/AIDS Epidemic level and trend in Nigeria

Number of ART sites 2002-2009

HIV Estimates by end of 2008 No of PLWH-2.95 million (Male-1.23, Female-1.72 million) Cumulative AIDS Death- 2.99million (Male-1.38, Female-1.61) Annual AIDS Death-280,000 (Male-123,000, Female-157,000) No. of Patients on ART 345,096 Adult 328,653 Childr 16,433 No requiring ART- 833,000 (Adult-740,000, Children-92,000) New infection- 380, 000 (Adult-323,000, Children- 57,000) Total AIDS orphans - 2.23million No. of ART Centres established 423

Classes of ARVs currently in use Nucleoside Reverse Transcriptase Inhibitors (NRTI’s) Non-nucloeside Reverse Transcriptase Inhibitors (NNTRI’s) Protease Inhibitors (PI’s) Zidovudine (AZT) Lamivudine (3TC) Didanosine (ddl) Zalcitabine (ddC Stavudine (d4T) Abacavir (ABC) Tenofovir Emtricitabine (FTC) Nevirapine (NVP) Efavirenz (EFV) Ritonavir (R) Indinavir (IDV) Saquinavir (SQV) Nelfinavir (NFV) Lopinavir (LPV) Amprenavir

Selection of Regimen in HIV/AIDS Programme Preferred 1st Line regimen: ZDV or TDF +3TC or FTC +EFV or NVP Other 1st Line option: ABC or d4T + 3TC or FTC +EFV or NVP Preferred 2nd Line regimen: TDF+3TC+ZDV+Lpv/r Recommended 2nd line regimen: AZT or d4T + 3TC or FTC + NVP or EFV

Number of ADR reports due to ARVs in NPC database Total ADR reports in NPC database 1507 Total ADR reports due to ARVs in NPC database 534 % of ADR reports due to ARVs 35.4%

OUR SUCCESSES Deeper awareness and precaution on HIV/AIDS through sustained enlightenment campaign Improved collaboration with HIV/AIDS Treatment centres in public health programmes & NGOs Feedback mechanism through newsletter etc

CHALLENGES Under detection and reporting of ADRs due to ARVs Inadequate political will & support from health institutional heads for staff to report. Failure of sponsors of Int’l public health programmes to forward reports to NPC. Funding

OUR FUTURE PLANS Online access to forms & reporting of ADRs. Looking forward to undertake active surveillance studies (CEM) on ARVs in Nigeria

THANK YOU FOR LISTENING